NCT03110744View on ClinicalTrials.gov

CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

December 15, 2017

Primary Completion Date

December 22, 2022

Study Completion Date

December 22, 2022

Conditions
Chordoma
Interventions
DRUG

Palbociclib

application on 21 consecutive days of a 28 days cycle

Trial Locations (3)

45147

Universitätsklinikum Essen, Essen

69120

National Center for Tumor Diseases, Heidelberg

89081

Universitätsklinikum Ulm, Ulm

All Listed Sponsors
lead

University Hospital Heidelberg

OTHER

NCT03110744 - CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma | Biotech Hunter | Biotech Hunter